Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Investigators identify two promising therapies to treat patients with acute megakaryocytic leukemia

Investigators identify two promising therapies to treat patients with acute megakaryocytic leukemia

MD Anderson introduces Moon Shots Program to reduce cancer deaths

MD Anderson introduces Moon Shots Program to reduce cancer deaths

Strand Life Sciences to validate and commercialize Trovagene's urine-based HPV test

Strand Life Sciences to validate and commercialize Trovagene's urine-based HPV test

PNAS: Ras proteins bring tension to the phosphate chain

PNAS: Ras proteins bring tension to the phosphate chain

MRD monitoring falls short in childhood AML assessment

MRD monitoring falls short in childhood AML assessment

Viral cause excluded for chronic fatigue syndrome

Viral cause excluded for chronic fatigue syndrome

Reduced-intensity benefits confirmed for AML cell transplantation

Reduced-intensity benefits confirmed for AML cell transplantation

No link between low-level electromagnetic field exposure from mobile phones and health risks

No link between low-level electromagnetic field exposure from mobile phones and health risks

AACR International Conference on Frontiers in Cancer Prevention Research to be held from Oct. 16-19

AACR International Conference on Frontiers in Cancer Prevention Research to be held from Oct. 16-19

No association between XMRV/pMLV and chronic fatigue syndrome

No association between XMRV/pMLV and chronic fatigue syndrome

Researchers clone T-cell receptor that binds to antigens associated with prostate and breast cancer

Researchers clone T-cell receptor that binds to antigens associated with prostate and breast cancer

ICREA researcher updates latest findings in applied epigenetics

ICREA researcher updates latest findings in applied epigenetics

NDC to advance study and treatment of Alzheimer's and other neurodegenerative diseases

NDC to advance study and treatment of Alzheimer's and other neurodegenerative diseases

Changes in physical characteristics of regulatory T cell can predict MDS progression risk

Changes in physical characteristics of regulatory T cell can predict MDS progression risk

MD Anderson joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

MD Anderson joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Researchers discover small DNA sequence that drives GATA2 protein

Researchers discover small DNA sequence that drives GATA2 protein

Flow cytometry renders PCR testing unnecessary for most AML patients

Flow cytometry renders PCR testing unnecessary for most AML patients

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

Leukemia & Lymphoma Society awards SCOR program grant to Walter and Eliza Hall Institute team

Leukemia & Lymphoma Society awards SCOR program grant to Walter and Eliza Hall Institute team

Toddlers with cancer more likely to develop trauma disorders than babies

Toddlers with cancer more likely to develop trauma disorders than babies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.